arginyl-glycyl-aspartic acid has been researched along with Cerebral Hemorrhage in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abumiya, T; Copeland, BR; del Zoppo, GJ; Fitridge, R; Koziol, JA; Mazur, C; Pierschbacher, MD; Tschopp, JF | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Cerebral Hemorrhage
Article | Year |
---|---|
Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia.
Topics: Animals; Basal Ganglia; Brain Ischemia; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibrinogen; Infarction, Middle Cerebral Artery; Male; Microcirculation; Oligopeptides; Papio; Peptides, Cyclic; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion; Vascular Patency | 2000 |